US 11,046,723 B2 · Process of controlling the impurities of clindamycin hydrochloride

Abstract

The invention provides a process of controlling the impurities of clindamycin hydrochloride, comprising a step of purifying said clindamycin hydrochloride by two-phase high performance liquid chromatography, wherein the chromatographic conditions are as follows: the detection wavelength is 200-220 nm; the column temperature is 20-40° C.; the flow rate is 0.8-1 ml/min; Mobile phase A: 0.025 mol/L potassium dihydrogen phosphate solution; Mobile phase B: Acetonitrile; and gradient elution is performed. The method of controlling impurities of the invention can solve the problem of the interference by excipients and the problem of the separation of many impurities at the same time. It also provides an effective method for setting quality standard of impurities in such a formulation.

Claims4

Dependent claims

A process of controlling the impurities of clindamycin hydrochloride, comprising a step of purifying said clindamycin hydrochloride by two-phase high performance liquid chromatography, wherein the chromatographic conditions are as follows:

the detection wavelength is 200-220 nm;
the column temperature is 20-40° C., wherein the chromatographic column is filled with octadecylsilane-bonded silica gel (250 mm×4.6 mm, 5 μm);
the flow rate is 0.8-1 ml/min;
Mobile phase A:
0.025 mol/L potassium dihydrogen phosphate solution;
the pH of Mobile phase A is 7.5;
Mobile phase B:
Acetonitrile;
Gradient elution:
Gradient elution is performed based on the following gradient conditions:
0-35 min:
10%-25% phase B;
35˜40 min:
10%-25%→30%-45% phase B;
40˜78 min:
30%-45% phase B;
78˜79 min:
30%-45%→10%-25% phase B;
79˜90 min:
10%-25% phase B.

17 more elements

Dependencies are inferred from the claim text.

Process of controlling the impurities of clindamycin hydrochloride

Life of this patent

Process of controlling the impurities of clindamycin hydrochloride

Life of this patent

Abstract

Claims4